The synthesis itself was deliberately straightforward. The researchers combined 1.5 millimoles of the starting carbohydrazide, ethyl 5-(4-chlorophenyl)-1-(1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)-2-methyl-1H-pyrrole-3-carboxylate, with 1.5 millimoles of isophthalaldehyde in 4.5 milliliters of glacial acetic acid. The reaction ran in a small sealed vial at 100 degrees Celsius for seven hours under continuous stirring, with progress tracked by thin-layer chromatography using a chloroform-ethanol mobile phase. Once complete, the addition of cold water precipitated the product, which was then purified by recrystallization. The final compound was characterized by infrared spectroscopy, proton and carbon-13 nuclear magnetic resonance, and melting point determination, confirming a pure solid product with a reported yield of 50.4 percent and a melting point of 117.1 to 118.1 degrees Celsius.

Encapsulation into micelles was accomplished using the film hydration method with a mixture of two Pluronic block copolymers, P123 and F127. Two milligrams of Y3 were dissolved in dioxane alongside solutions of each Pluronic, the solvent was evaporated to leave a thin film, and the film was redispersed in purified water and filtered. The amount of compound that failed to load was measured spectrophotometrically at 275 nanometers against a standard curve, allowing calculation of both encapsulation efficiency and loading degree. The encapsulation efficiency proved remarkably high at 99.8 percent, meaning nearly all of the synthesized hydrazone ended up inside the micellar carriers rather than remaining free in solution.

A central motivation for the micellar approach was solubility. Hydrazones as a class are generally soluble in organic solvents such as ethanol, methanol, dimethylformamide, and dimethyl sulfoxide, but aqueous solubility can be limiting for biological testing and eventual pharmaceutical development. Polymeric micelles are well established as carriers that can improve the stability of poorly water-soluble molecules, protect them from enzymatic and chemical degradation, enable controlled release, and enhance penetration across biological barriers including the blood-brain barrier. In this study, the authors also noted that micellar systems may alter cellular uptake mechanisms by facilitating interactions with biological membranes or promoting endocytic pathways, potentially influencing the compound’s pharmacodynamics.

Before any neuroprotection testing, the team examined whether Y3 or its micellar formulation could inhibit the enzymes monoamine oxidase A and B, targets of long-standing interest in Parkinson’s disease research because MAO-B catalyzes reactions in dopamine metabolism that generate reactive oxygen species. Using a fluorometric assay with recombinant human enzymes and Amplex UltraRed reagent, the researchers tested both compounds at a concentration of 1 microgram per milliliter, with eight samples per substance and fluorescence monitored over 150 minutes. The result was clear: neither Y3 nor Y3_micelles showed any statistically significant MAO-A or MAO-B inhibitory activity at that concentration. This finding is notable because the original framing of the work referenced pyrrole hydrazones as promising MAO-B inhibitors, but the experimental data in this study did not demonstrate such inhibition for this particular compound at the dose tested.

The neurotoxicity screening came next, with the compounds tested at fixed concentrations of 100 micrograms per milliliter alone and 50 micrograms per milliliter in the neurotoxicity models. When applied alone at 100 micrograms per milliliter to isolated rat brain synaptosomes for one hour, both compounds produced low but statistically significant neurotoxic effects on synaptosomal viability and reduced glutathione levels compared with untreated controls. Pure Y3 decreased synaptosomal viability by 30 percent and glutathione by 25 percent, while the micellar formulation was gentler, reducing viability by 25 percent and glutathione by only 10 percent. A similar pattern emerged in isolated rat brain mitochondria, where Y3 decreased glutathione by 40 percent and increased malondialdehyde production, a marker of lipid peroxidation, by 35 percent, whereas Y3_micelles decreased glutathione by 30 percent and raised malondialdehyde by only 15 percent. In microsomes, both compounds showed pro-oxidant effects, with Y3 increasing malondialdehyde by 40 percent and Y3_micelles by 20 percent.

The protective side of the story emerged when the compounds were tested against three distinct models of induced neurotoxicity, each at a concentration of 50 micrograms per milliliter with a 30-minute pre-incubation before the toxic agent was introduced. In synaptosomes exposed to 150 micromolar 6-hydroxydopamine, a toxin that selectively damages dopaminergic neurons by generating reactive oxygen species and is widely used to mimic aspects of Parkinson’s disease, the toxic agent alone cut synaptosomal viability and glutathione by 50 percent. Against this damage, Y3 preserved 50 percent of synaptosomal viability and 40 percent of glutathione relative to the toxic control, while Y3_micelles preserved 60 percent of viability and a striking 70 percent of glutathione.

In mitochondria challenged with 75 micromolar tert-butyl hydroperoxide, which alone reduced glutathione by 50 percent and increased malondialdehyde production by 150 percent, both compounds again delivered significant neuroprotective and antioxidant effects. Y3 preserved 40 percent of the glutathione level and decreased malondialdehyde production by 40 percent compared with the toxic agent, while Y3_micelles preserved 60 percent of glutathione and decreased malondialdehyde by 100 percent relative to the toxin. The third model used iron sulfate and ascorbic acid to trigger nonenzymatic lipid peroxidation in microsomes through Fenton chemistry, which generates hydroxyl radicals and raised malondialdehyde production by 250 percent over controls. Here Y3 reduced malondialdehyde by 29 percent and Y3_micelles by 43 percent compared with the toxic agent, and the authors noted that microsomes serve as a model of the lipid membrane environment where such peroxidation matters.

Across all three models, the pattern was consistent: micellar incorporation enhanced both the safety profile and the neuroprotective and antioxidant performance of the hydrazone. The authors attribute this to the micellar carrier’s ability to improve aqueous solubility, protect the compound from degradation, and potentially alter how it interacts with biological membranes. The experiments were conducted on subcellular fractions isolated from nine male Wistar rats, with synaptosomes, mitochondria, and microsomes prepared by Percoll gradient centrifugation and protein content measured by the Lowry method. Statistical analysis relied on one-way analysis of variance with Dunnett’s post hoc test for the enzyme assays and the nonparametric Mann-Whitney test for the subcellular fraction experiments, with six experiments per condition.

Several important caveats frame these findings. All results come from in vitro work on isolated rat brain subcellular fractions, not from living animals or human cells, so the neuroprotective effects cannot be extrapolated directly to clinical benefit. The compounds were tested at only a few fixed concentrations, and the absence of MAO inhibition at 1 microgram per milliliter does not rule out activity at other doses. The 6-hydroxydopamine, tert-butyl hydroperoxide, and iron-ascorbate models each capture only specific facets of oxidative and neurodegenerative damage.

Subject of Research: Micellar formulation of a synthetic pyrrole hydrazone and its neuroprotective effects in rat brain in vitro models

Article Title: Pyrrole hydrazone-based nanoparticles as MAO-B inhibitors: effect of micelle-assisted delivery

Article References: Gurbeva, Y., Radeva, L., Peikova, L., Kondeva-Burdina, M., Yoncheva, K., & Georgieva, M. (2026). Pyrrole hydrazone-based nanoparticles as MAO-B inhibitors: effect of micelle-assisted delivery. Pharmacia, 73, Article e200746. https://doi.org/10.3897/pharmacia.73.e200746

Image Credits: AI Generated

DOI: 10.3897/pharmacia.73.e200746

Keywords: pyrrole hydrazone, polymeric micelles, Pluronic, neuroprotection, antioxidant, 6-hydroxydopamine, tert-butyl hydroperoxide, lipid peroxidation, synaptosomes, mitochondria, microsomes, monoamine oxidase